跳至主要内容
临床试验/NL-OMON38188
NL-OMON38188已完成不适用

Potential of patient derived vascular cells for usage in vascular tissue engineering - Patient derived cells for vascular tissue engineering

niversiteit Maastricht0 个研究点目标入组 95 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All groups: Age>18 years
  • Group A: Patients undergoing elective bypass surgery for coronary arterial disease in which the saphenous vein is used as bypass graft.
  • Group B: Patients receiving an AV-shunt in which a native arm vein is used for creation of the loop and which are having renal failure. Patients undergoing kidney transplantation.
  • Group C: Age/sex-matched patients undergoing surgical procedures in which small vessels are usually ligated or removed. Examples of these surgical procedures include thyroidectomy, inguinal hernia repair, or sarcoma resection.

排除标准

  • All groups: Age <18 years
  • Patients who will not provide informed consent.
  • Group C: History of cardiovascular disease, e.g. hypertension, hypercholesterolemia, diabetes, angina pectoris, myocardial infarction, cerebrovascular accident or peripheral arterial disease and chronic kidney disease. Smoking, or history of smoking in the last 15 years.

研究者

相似试验